Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria T Abreu

Showing results (161-170 of 219) with videos related to

Pageof 22
Sort By:
Clinical and Translational Gastroenterology|June 3, 2024
Stromal-Like Cells Are Found in Peripheral Blood of Patients With Inflammatory Bowel Disease and Correlate With Immune Activation StateAmanda M Honan, Gillian E Jacobsen, Hannah Drum, et al.
Journal of Clinical Gastroenterology|December 13, 2005
Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's diseaseMaria T Abreu, Jordan L Geller, Eric A Vasiliauskas, et al.
Gastroenterology|January 30, 2007
NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relativesShane M Devlin, Huiying Yang, Andrew Ippoliti, et al.
Inflammatory Bowel Diseases|January 9, 2009
Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot studyMaria T Abreu, Christian von Tirpitz, Robert Hardi, et al.
The American Journal of Gastroenterology|December 14, 2023
Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-Term Maintenance StudyWaqqas Afif, Ramesh P Arasaradnam, Maria T Abreu, et al.
The New England Journal of Medicine|September 26, 2019
Ustekinumab as Induction and Maintenance Therapy for Ulcerative ColitisBruce E Sands, William J Sandborn, Remo Panaccione, et al.
Crohn'S & Colitis 360|February 13, 2023
Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab ReintroductionInessa Normatov, Daniela Fluxa, Jingzhou D Wang, et al.
Gastrointestinal Endoscopy|October 19, 2024
Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel, Bo Shen, Maria T Abreu, et al.
Inflammatory Bowel Diseases|April 26, 2020
Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBDJuan F Burgueño, Adrian Reich, Hajar Hazime, et al.
Journal of Crohn'S & Colitis|March 3, 2022
Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term ExtensionMaria T Abreu, David S Rowbotham, Silvio Danese, et al.
Pageof 22

Showing results (161-170 of 219) with videos related to

Sort By:
Pageof 22
Clinical and Translational Gastroenterology|June 3, 2024
Stromal-Like Cells Are Found in Peripheral Blood of Patients With Inflammatory Bowel Disease and Correlate With Immune Activation StateAmanda M Honan, Gillian E Jacobsen, Hannah Drum, et al.
Journal of Clinical Gastroenterology|December 13, 2005
Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's diseaseMaria T Abreu, Jordan L Geller, Eric A Vasiliauskas, et al.
Gastroenterology|January 30, 2007
NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relativesShane M Devlin, Huiying Yang, Andrew Ippoliti, et al.
Inflammatory Bowel Diseases|January 9, 2009
Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot studyMaria T Abreu, Christian von Tirpitz, Robert Hardi, et al.
The American Journal of Gastroenterology|December 14, 2023
Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-Term Maintenance StudyWaqqas Afif, Ramesh P Arasaradnam, Maria T Abreu, et al.
The New England Journal of Medicine|September 26, 2019
Ustekinumab as Induction and Maintenance Therapy for Ulcerative ColitisBruce E Sands, William J Sandborn, Remo Panaccione, et al.
Crohn'S & Colitis 360|February 13, 2023
Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab ReintroductionInessa Normatov, Daniela Fluxa, Jingzhou D Wang, et al.
Gastrointestinal Endoscopy|October 19, 2024
Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel, Bo Shen, Maria T Abreu, et al.
Inflammatory Bowel Diseases|April 26, 2020
Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBDJuan F Burgueño, Adrian Reich, Hajar Hazime, et al.
Journal of Crohn'S & Colitis|March 3, 2022
Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term ExtensionMaria T Abreu, David S Rowbotham, Silvio Danese, et al.
Pageof 22